GE HealthCare (GEHC) announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease. To complement its MR-guided AI-assisted scanning expertise with analysis and reporting in neurological disease assessment, GE HealthCare expects to integrate the icometrix icobrain platform with its MRI systems for workflow. The consummation of the transaction is subject to customary closing conditions, including regulatory approvals. Financial details of the transaction have not been disclosed publicly. GE HealthCare intends to fund this transaction with cash on hand.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Balanced Outlook for GE Healthcare: Strong Growth Amidst Near-Term Challenges
- GE HealthCare announces distribution, services agreement with CardioNavix
- Cooperman’s Omega bought Atlas Energy and ArriVent in Q2
- GE HealthCare price target raised to $93 from $89 at Citi
- Cautious Outlook for GE Healthcare Technologies: Hold Rating Maintained Amid Market Expectations and Trade Uncertainties